Long-term use of interferon-β in multiple sclerosis increases Vδ1−Vδ2−Vγ9− γδ T cells that are associated with a better outcome

New from #mssocietyuk https://t.co/wkGnPLn5Dp Long-term use of interferon-β in multiple sclerosis increases Vδ1−Vδ2−Vγ9− γδ T cells that are associated with a better outcome

RT @ingentium_ms: Long-term use of interferon-β in #MultipleSclerosis #MS increases Vδ1Vδ2Vγ9 γδ T cells that are associated with a better…

Long-term use of interferon-β in #MultipleSclerosis #MS increases Vδ1Vδ2Vγ9 γδ T cells that are associated with a better outcome. https://t.co/TwQNCuro6o